Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-31 Sale |
2022-10-31 7:37 pm |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
5,012 | $7.93 | $39,745 | 46,734 (Direct) |
View |
| 2022-07-05 Purchase |
2022-07-07 5:00 pm |
Seres Therapeutics Inc. | MCRB | Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
8,738,243 | $3.15 | $27,525,465 | 17,617,352 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-27 Option Award |
2023-05-01 4:43 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
42,500 | $0 | 166,613 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-01 4:41 pm |
2023-04-27 2027-06-18 |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
35,000 | $0 | 70,000 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 5:50 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
142,500 | $0 | 142,500 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 5:48 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
142,500 | $0 | 142,500 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 5:46 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 5:45 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
127,500 | $0 | 127,500 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 5:45 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
375,000 | $0 | 375,000 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 5:44 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
127,500 | $0 | 127,500 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 5:43 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
212,500 | $0 | 212,500 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 5:42 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Cloghessy Paula See Remarks |
142,500 | $0 | 142,500 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 4:35 pm |
N/A 2033-01-03 |
Seres Therapeutics Inc. | MCRB | Fraser Claire Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2022-10-27 Option Award |
2022-10-31 7:37 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
20,000 | $0 | 46,734 (Direct) |
View |
| 2022-06-15 Exercise |
2022-10-31 6:05 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
5,000 | $0 | 112,992 (Direct) |
View |
| 2022-10-27 Option Award |
2022-10-31 6:05 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
42,500 | $0 | 112,992 (Direct) |
View |
| 2022-09-08 Option Award |
2022-09-09 4:46 pm |
2022-09-08 2027-07-18 |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
35,000 | $0 | 35,000 (Direct) |
View |
Ownership |
2022-07-07 5:00 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. 10% Owner |
0 | $0 | 5,825,495 (Indirect) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:29 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
63,492 | $3.15 | 104,546 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:27 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
47,619 | $3.15 | 47,619 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:25 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Cloghessy Paula See Remarks |
31,746 | $3.15 | 31,746 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:23 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
63,492 | $3.15 | 65,492 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:23 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Kender Richard N Director |
63,492 | $3.15 | 63,492 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:22 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
31,746 | $3.15 | 31,746 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:22 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Dere Willard H Director |
31,746 | $3.15 | 31,746 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:21 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
63,492 | $3.15 | 96,334 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:19 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Zausner Meryl Director |
31,746 | $3.15 | 31,746 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 7:19 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Biondi Paul Director |
47,619 | $3.15 | 47,619 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:36 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Kender Richard N Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:35 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Zausner Meryl Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:35 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Graves Kurt Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:35 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Biondi Paul Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:32 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Zausner Meryl Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:32 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Kender Richard N Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:32 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Graves Kurt Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:31 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Behar Gregory Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:31 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:30 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Berenson Stephen Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:30 pm |
N/A 2032-06-21 |
Seres Therapeutics Inc. | MCRB | Dere Willard H Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-02-07 Option Award |
2022-02-08 9:35 pm |
N/A 2032-02-06 |
Seres Therapeutics Inc. | MCRB | Cloghessy Paula See Remarks |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:30 pm |
N/A 2032-02-03 |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
175,000 | $0 | 175,000 (Direct) |
View |